Connect with us

Tampa General Hospital gets new Covid-19 treatment

November 19, 2020 - Tampa General Hospital said it is one of the first hospitals in the United States to provide monoclonal antibody treatments to some patients with Covid-19. The treatment from Eli Lilly (NYSE: LLY) was recently approved by the U.S. Food and Drug Administration under an emergency use authorization. It's for the treatment of patients with mild to moderate symptoms from Covid-19 before they deteriorate further or require hospitalization. It is a single dose infusion-based treatment that is provided on an outpatient basis and marks a dramatic shift in Covid-19 care, a news release from Tampa General said. Production is just ramping up and there is a limited supply of the treatment, so physicians are only approving its use on high-risk patients, the hospital said. Tampa General received some of the first supplies in the country and has the option to request additional doses on a weekly basis, the hospital said.

More Zaps Frontpage

The St. Pete Catalyst

The Catalyst honors its name by aggregating & curating the sparks that propel the St Pete engine.  It is a modern news platform, powered by community sourced content and augmented with directed coverage.  Bring your news, your perspective and your spark to the St Pete Catalyst and take your seat at the table.

Email us: spark@stpetecatalyst.com

Subscribe for Free

Share with friend

Please enter email address you want to share this article with